Phase 2 Refractory Epilepsy Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy
Refractory EpilepsyMedically refractory epilepsyDrug Resistant Epilepsy
Madeline Fields8 enrolled1 locationNCT05019885
Active
Phase 2
Efficacy And Withdrawal Symptoms in Transition Between Cannabidivarin (CBDV) and Cannabidiol (CBD) in Children with Rett Syndrome and Refractory Epilepsy
Refractory EpilepsyRett Syndrome
Sydney Children's Hospital Network3 enrolled1 locationACTRN12624000948594
Completed
Phase 2
A study to assess the long term retention on treatment and long-term safety and tolerability of Triheptanoin in male and female participants with drug-resistant epilepsy
Medically refractory epilepsy
University of Queensland12 enrolled1 locationACTRN12615000406505
Completed
Phase 2
A safety and feasibility study of oral Triheptanoin as an add on treatment for patients (12 years or older) with medical refractory epilepsy.
Medical refractory epilepsy
University of Queensland60 enrolled1 locationACTRN12612000226808